Oxford vaccine against deadly Nipah virus granted EMA PRIME designation

National Health Executive

11 June 2025 - The University of Oxford’s vaccine to protect people from deadly Nipah virus has been granted support from the PRIority MEdicines (PRIME) scheme offered by Europe’s medicines regulator, the EMA. 

It is the first UK academic institution to be awarded this designation.

Read National Health Executive article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Europe , Vaccine , Priority review